UPDATE : Monday, September 7, 2020
상단여백
Anticancer drug Riavax used more in last-stage cancer patients
The number of last-stage cancer patients who received emergency treatments ...
by So Jae-hyeon  |  2018-09-13 15:25
라인
Pharma outlook gloomy amid tax probes, reduced biz days
The pharmaceutical industry in Korea is expected to suffer sales declines i...
by So Jae-hyeon  |  2018-09-13 14:39
라인
‘Regulator’s scrutiny into ToolGen’s patent issue might discourage biotech research’
The biotech industry is paying close attention to how the recent controvers...
by So Jae-hyeon  |  2018-09-12 14:25
라인
MERS infection affects stock market
Pharmaceuticals and biotech businesses are gathering renewed attention afte...
by So Jae-hyeon  |  2018-09-10 16:25
라인
‘Sky Labs’ wearable heart rhythm tracker effective’
Sky Labs made a presentation on the effect of using a wearable device for c...
by So Jae-hyeon  |  2018-09-05 16:12
라인
Pfizer seeks Yuhan’s help to keep anti-smoking drug rolling
Pfizer has picked Yuhan Corp. as a partner to defense its smoking cessation...
by So Jae-hyeon  |  2018-09-05 11:59
라인
Pharmaceuticals seek niche with drug reformulation
Local pharmaceutical companies are striving to find a niche market by chang...
by So Jae-hyeon  |  2018-09-03 16:49
라인
Will ‘world’s first’ dog dementia treatment work?
A Korean drug company working on a treatment for dementia in dogs said that...
by So Jae-hyeon  |  2018-09-03 15:44
라인
Biotech’s big license-out deals calm concerns about bubble
Korean pharmaceutical and biotech companies have won 1.7 trillion won ($1.5...
by So Jae-hyeon  |  2018-09-03 14:21
라인
‘₩5 trillion Thai market attractive to Korean drugmakers
Korean drugmakers should aggressively seek to tap into Thailand’s pharmaceu...
by So Jae-hyeon  |  2018-08-31 16:27
라인
Global ban on promotional aids adds burden on local drugmakers
Korean pharmaceutical firms are agonizing over the latest code of ethics by...
by So Jae-hyeon  |  2018-08-31 14:35
라인
Pharmaceuticals criticize tougher disclosure rules
Pharmaceutical industry officials are continuing to complain about the fina...
by So Jae-hyeon  |  2018-08-29 12:02
라인
Viagra impotent in competition against generics
Viagra (ingredient: sildenafil), the favored treatment for erectile dysfunc...
by So Jae-hyeon  |  2018-08-28 16:05
라인
Korea’s Botox export to China plummet amid crackdown on smuggling
The poor earnings by botulinum toxin makers Medytox and Hugel have somethin...
by So Jae-hyeon  |  2018-08-17 16:27
라인
Biotech firms grudge over regulator’s plan to toughen disclosure rules
Pharmaceutical and biotech industry officials are expressing discontent ove...
by So Jae-hyeon  |  2018-08-17 11:51
라인
Will Tego Science win reimbursement for diabetic foot ulcer treatment?
Tego Science is seeking to obtain insurance coverage for Kaloderm, a biolog...
by So Jae-hyeon  |  2018-08-16 11:34
라인
Parkinson’s drug Azilect beats market leader Stalevo
A rising star drug in the Parkinson’s disease treatment market defeated the...
by So Jae-hyeon  |  2018-08-13 15:32
라인
[News Focus] Valsartan chaos reveals Korean drugmakers’ weakness
The pharmaceutical industry is having time for self-reflection, admitting t...
by So Jae-hyeon  |  2018-08-13 14:21
라인
Competition heats up among Korean Botox makers to develop ‘kDa’
As the global expansion of domestic botulinum toxin (BTX) products is becom...
by So Jae-hyeon  |  2018-08-08 16:53
라인
Over 36.8 billion won worth of banned valsartan-based drugs sold last year
More than 36.9 billion won worth of banned antihypertensive drugs were pres...
by So Jae-hyeon  |  2018-08-07 15:40
여백
여백
여백
Back to Top